Pharmacokinetic (PK) Profile of Rabeprazole in Patients Aged 12–16 Years with Gastroesophageal Reflux Disease (GERD)

MLA

Josephine Reyes, et al. “Pharmacokinetic (PK) Profile of Rabeprazole in Patients Aged 12–16 Years with Gastroesophageal Reflux Disease (GERD).” American Journal of Gastroenterology, vol. 100, Sept. 2005, p. S377. EBSCOhost, https://doi.org/10.14309/00000434-200509001-01034.

APA

Josephine Reyes, Shanti Varughese, Philip D. Walson, Kathleen Lomax, & Laura P. James. (2005). Pharmacokinetic (PK) Profile of Rabeprazole in Patients Aged 12–16 Years with Gastroesophageal Reflux Disease (GERD). American Journal of Gastroenterology, 100, S377. https://doi.org/10.14309/00000434-200509001-01034

Chicago

Josephine Reyes, Shanti Varughese, Philip D. Walson, Kathleen Lomax, and Laura P. James. 2005. “Pharmacokinetic (PK) Profile of Rabeprazole in Patients Aged 12–16 Years with Gastroesophageal Reflux Disease (GERD).” American Journal of Gastroenterology 100 (September): S377. doi:10.14309/00000434-200509001-01034.